Myasthenic crisis: Clinical features, complications and mortality

Neurology India

Volumn 53, Issue 1, 2005, Pages 37-40

  Murthy, J M K ^a   Meena, A K ^b   Chowdary, G V S ^a   Naryanan, Jaishree T ^a  

^a CARE HOSPITAL   (India)

^b NIZAM'S INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Intravenous immunoglobulins; Mechanical ventilation; Myasthenic crisis; Plasma exchange

Indexed keywords

IMMUNOGLOBULIN;

ADULT; AGED; ARTICLE; ATELECTASIS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEPRESSION; DIARRHEA; DISEASE DURATION; EXTUBATION; HUMAN; INFECTION COMPLICATION; INTENSIVE CARE UNIT; LENGTH OF STAY; MORTALITY; MYASTHENIA GRAVIS; MYASTHENIC CRISIS; NEUROMUSCULAR DISEASE; PLASMAPHERESIS; RETROSPECTIVE STUDY; SEPSIS; SEPTICEMIA; THYMOMA; URINARY TRACT INFECTION; VENTILATOR ASSOCIATED PNEUMONIA;

EID: 17444411864     PISSN: 00283886     EISSN: None     Source Type: Journal    
DOI: 10.4103/0028-3886.15050     Document Type: Article

References (23)

1. Kirmani JF, Yahia AM, Qureshi AI. Myasthenic crisis. Curr Treat Options Neurology 2004;6:3-15.
2. Jaretzki A III, Baroho RJ, Ernstoff RM, Kaminski HJ, Keesey JC, Penn AS, et al. Myasthenia gravis recommendations for clinical research standards: Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Neurology 2000;55:16-23.
3. Thomas CE, Mayer SA, Gungor Y, Swarup R, Webster EA, Chang I, et al. Myasthenic crisis: Clinical features, mortality complications and risk factors for prolonged intubation. Neurology 1997;48:1253-60.
4. Mayer SA. Intensive Care of the myasthenic patient. Neurology 1997;48:S70-S75.
5. Panda S, Goyal V, Behari M, Singh S, Srivastava T. Myasthenic crisis: A retrospective study. Neurol India 2004;52:453-6.
6. Meena AK, Prasad VS, Murthy JMK. Neurological intensive care in India - Disease spectrum and outcome. Neurol India 2001;49:S1-S7.
7. Aggarwal AN, Gupta D, Behara D, Prabhakar S, Jindal SK. Intensive respiratory care in patients with myasthenic crisis. Neurol India 2001;50:348-51.
8. nd Ed. 2003. p. 422-36.
9. Juel VC. Myasthenia gravis: Management of myasthenic crisis and perioperative care. Semin Neurol 2004;24:75-81.
10. Putman MR, Wise RA. Myasthenia gravis and upper airway obstruction. Chest 1996:109:400-04.
11. Nomori H, Ishihara T. Pressure-controlled ventilation via a mini-tracheostomy tube for patients with neuromuscular disease. Neurology 2000;55:698-702.
12. Rabistein A, Wijdicks EFM. BiPAP in acute respiratory failure due to myasthenic crisis may prevent intubation. Neurology 2002;59:1647-9.
13. Gracey DR, Divertie MB, Howard FM. Mechanical ventilation for respiratory failure in myasthenia gravis. Two-year experience with 22 patients. Mayo Clin Proc 1983;58:597-602.
14. Varelas PN, Chua HC, Natterman J, Barmadia L, Zimmerman P, Yahia A, et al. Ventilatory care in myasthenia gravis crisis: Assessing the baseline adverse event rate. Crit Care Med 2002;30:2663-8.
15. Gajdos P, Chevert S, Clair B, Tranchant C, Chastang C. Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis. Myasthenia Gravis Clinical Study. Ann Neurol 1997;41:789-96.
16. Ronager J, Ravnborg M, Hermansen I, Vorstrup S. Immunoglobulin treatment versus plasma exchange in patients with chronic moderate to severe myasthenia gravis. Artif Organs 2001;25:967-73.
17. Yeh JH, Chiu HC. Plasmapheresis in myasthenia gravis: A comparative study of daily versus alternately daily schedule. Acta Neruol Scand 1999;99:147-51.
18. Qureshi AI, Choudary MA, Akbar MS, Mohammad Y, Chua HC, Yahia AM, et al. Plasma exchange versus intravenous immunoglobulin treatment in myasthenic crisis. Neurology 1999;52:629-32.
19. Tether JE. Management of myasthenic and cholinergic crises. Am J Med 1955;19:740-2.
20. Osserman KE, Genkins G. Studies in myasthenia gravis: Reduction in mortality rate after crisis. JAMA 1963;183:97-101.
21. Bedlack RS, Sandrs DB. How to handle myasthenic crisis. Postgrad Med 2000;107:211-4;220-2.
22. Klein CM, Vernino S, Lennon VA, Sandroni P, Fealey RD, Benrud-Larson L, et al. The spectrum of autoimmune autonomic neuropathies. Ann Neurol 2003;53:752-3.
23. Vernino S, Low PA, Fealey RD, Stewart JD, Farrugia G, Lennon VA. Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. N Eng J Med 2000;343:847-55.